FIGURE 1.
Patient responses. Swimmer's plot of responses to regorafenib in patients enrolled in phase 1 study of regorafenib in advanced myeloid malignancies
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.